[go: up one dir, main page]

NO991158D0 - FremgangsmÕte for behandling av amyotrofisk lateralsklerose - Google Patents

FremgangsmÕte for behandling av amyotrofisk lateralsklerose

Info

Publication number
NO991158D0
NO991158D0 NO991158A NO991158A NO991158D0 NO 991158 D0 NO991158 D0 NO 991158D0 NO 991158 A NO991158 A NO 991158A NO 991158 A NO991158 A NO 991158A NO 991158 D0 NO991158 D0 NO 991158D0
Authority
NO
Norway
Prior art keywords
procedure
treatment
lateral sclerosis
amyotrophic lateral
amyotrophic
Prior art date
Application number
NO991158A
Other languages
English (en)
Other versions
NO991158L (no
Inventor
Georg Haase
Axel Kahn
Philippe Kennel
Jacques Mallet
Fruduric Revah
Original Assignee
Rh Ne Poulenc Rorer Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rh Ne Poulenc Rorer Sa, Inst Nat Sante Rech Med filed Critical Rh Ne Poulenc Rorer Sa
Publication of NO991158L publication Critical patent/NO991158L/no
Publication of NO991158D0 publication Critical patent/NO991158D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO991158A 1996-09-13 1999-03-10 FremgangsmÕte for behandling av amyotrofisk lateralsklerose NO991158D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611186A FR2753379B1 (fr) 1996-09-13 1996-09-13 Methode de traitement de la sclerose laterale amyotrophique
PCT/FR1997/001589 WO1998011213A1 (fr) 1996-09-13 1997-09-10 Methode de traitement de la sclerose laterale amyotrophique

Publications (2)

Publication Number Publication Date
NO991158L NO991158L (no) 1999-03-10
NO991158D0 true NO991158D0 (no) 1999-03-10

Family

ID=9495715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991158A NO991158D0 (no) 1996-09-13 1999-03-10 FremgangsmÕte for behandling av amyotrofisk lateralsklerose

Country Status (16)

Country Link
US (1) US6723315B1 (no)
EP (1) EP0929671A1 (no)
JP (1) JP2001504088A (no)
KR (1) KR20010029506A (no)
CN (1) CN1155706C (no)
AU (1) AU740641B2 (no)
BR (1) BR9711955A (no)
CA (1) CA2259283A1 (no)
CZ (1) CZ84799A3 (no)
FR (1) FR2753379B1 (no)
HU (1) HUP9903779A3 (no)
IL (1) IL128185A0 (no)
NO (1) NO991158D0 (no)
SK (1) SK31899A3 (no)
WO (1) WO1998011213A1 (no)
ZA (1) ZA978257B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471812C (en) * 2001-12-21 2012-09-04 The Salk Institute For Biological Studies Targeted retrograde gene delivery to motor neurons
US20070049630A1 (en) * 2005-08-24 2007-03-01 Allergan, Inc. Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis
JP2011527317A (ja) * 2008-07-11 2011-10-27 グラクソ グループ リミテッド Ｎｏｇｏ−ａアンタゴニストによる筋萎縮性側索硬化症の治療
US9539307B2 (en) 2012-09-17 2017-01-10 The Research Institute At Nationwide Children's Hospital Compositions and methods for treating amyotrophic lateral sclerosis
JP2016538276A (ja) 2013-11-05 2016-12-08 ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルＴｈｅ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ａｔ Ｎａｔｉｏｎｗｉｄｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ 筋萎縮性側索硬化症の処置のためのＮＦ−κＢおよびＳＯＤ−１を阻害する組成物および方法
WO2017173234A1 (en) * 2016-03-31 2017-10-05 University Of Cincinnati Methods and compositions for the treatment of als
IL280965B2 (en) * 2018-08-30 2025-06-01 Univ Rowan Methods of treating or preventing amyotrophic lateral sclerosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
DE69334238D1 (de) * 1992-09-25 2008-09-25 Aventis Pharma Sa Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
FR2717496B1 (fr) * 1994-03-18 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2717824B1 (fr) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2724945B1 (fr) 1994-09-27 1996-12-27 Centre Nat Rech Scient Vecteurs viraux et utilisation en therapie genique
BR9810500A (pt) 1997-06-30 2000-09-05 Rhone Poulenc Rorer Sa Sistema e aparelho para a transferência de ácido nucléico in vivo para o interior de células de organismos eucarióticos pluricelulares

Also Published As

Publication number Publication date
CN1155706C (zh) 2004-06-30
BR9711955A (pt) 1999-08-24
ZA978257B (en) 1998-03-24
US6723315B1 (en) 2004-04-20
WO1998011213A1 (fr) 1998-03-19
AU740641B2 (en) 2001-11-08
HUP9903779A3 (en) 2002-01-28
NO991158L (no) 1999-03-10
KR20010029506A (ko) 2001-04-06
FR2753379B1 (fr) 1998-10-30
CN1225131A (zh) 1999-08-04
CZ84799A3 (cs) 1999-06-16
EP0929671A1 (fr) 1999-07-21
CA2259283A1 (fr) 1998-03-19
JP2001504088A (ja) 2001-03-27
HUP9903779A2 (hu) 2000-03-28
AU4212597A (en) 1998-04-02
SK31899A3 (en) 1999-10-08
FR2753379A1 (fr) 1998-03-20
IL128185A0 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
NO986054D0 (no) Antikonvulsive derivater for behandling av amyotrofisk lateral sklerose (AL
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO984431D0 (no) FremgangsmÕte for behandling av smerte
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO991955L (no) FremgangsmÕte for behandling av hydrokarboner
NO972909D0 (no) Substituerte azetidin-2-oner for behandling av atherosklerose
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO976121D0 (no) Fremgangsmåte for fremstilling av karbonylforbindelser
NO20003042L (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO970668D0 (no) Fremgangsmåte for fremstilling av peroksidholdig perfluorpolyoxyalkylener
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
NO984446D0 (no) FremgangsmÕte for behandling av smerte
NO983068D0 (no) FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser
NO991460D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av seborÚisk dermatitt
NO991158L (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
ID17472A (id) Sekat pencegah kebocoran
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO982562D0 (no) Sammensetning for behandling av smerte
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application